- Home
- WTBA vs ALT Comparison
WTBA vs ALT Comparison
Compare WTBA & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WTBA | ALT |
|---|---|---|
| Founded | 1893 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.4M | 421.5M |
| IPO Year | 2002 | 2005 |
Fundamental Metrics
Financial Performance| Metric | WTBA | ALT |
|---|---|---|
| Price | $28.07 | $2.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $24.00 | $17.67 |
| AVG Volume (30 Days) | 48.9K | ★ 3.7M |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.17% | N/A |
| EPS Growth | ★ 35.21 | 25.37 |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | ★ $41,000.00 |
| Revenue This Year | $23.80 | N/A |
| Revenue Next Year | $9.39 | N/A |
| P/E Ratio | $22.36 | ★ N/A |
| Revenue Growth | N/A | ★ 105.00 |
| 52 Week Low | $17.50 | $2.56 |
| 52 Week High | $28.44 | $6.44 |
Technical Indicators
Market Signals| Indicator | WTBA | ALT |
|---|---|---|
| Relative Strength Index (RSI) | 65.96 | 52.35 |
| Support Level | $23.39 | $2.87 |
| Resistance Level | N/A | $3.09 |
| Average True Range (ATR) | 0.77 | 0.17 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 82.30 | 36.61 |
Price Performance
Historical ComparisonAbout WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.
About ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.